Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Cole

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Drug News & Perspectives|February 16, 2010
Accelerating drug development and approvalPatrick Cole
Drug News & Perspectives|February 18, 2009
Insights into inflammatory mechanisms and new therapeutic strategiesPatrick Cole
Drugs of Today (Barcelona, Spain : 1998)|May 10, 2003
Esomeprazole: A significant advance beyond omeprazole in the treatment of acid-related diseaseXavier Rabasseda, Patrick Cole
The Journal of Craniofacial Surgery|November 13, 2007
Mental training in surgical education: a randomized, controlled trialPatrick Cole, Larry Hollier
Drug News & Perspectives|April 7, 2010
Chronicles in drug discoveryPatrick Cole, Sylvia Vasiliou
Drugs of Today (Barcelona, Spain : 1998)|February 13, 2003
Frovatriptan: a selective type 1B/1D serotonin receptor agonist for the treatment of migraine headachePatrick Cole, Xavier Rabasseda
Drugs of Today (Barcelona, Spain : 1998)|December 18, 2004
Quetiapine in bipolar disorder: Increasing evidence of efficacy and tolerabilityPatrick Cole, Xavier Rabasseda
Drugs of Today (Barcelona, Spain : 1998)|August 6, 2005
Enhanced hypercholesterolemia therapy: the ezetimibe/simvastatin tabletPatrick Cole, Xavier Rabasseda
Drug News & Perspectives|December 18, 2009
Chronicles in drug discoveryPatrick Cole, Sylvia Vasiliou
Drugs of Today (Barcelona, Spain : 1998)|January 13, 2005
Tegaserod: a serotonin 5-HT4 receptor agonist for treatment of constipation-predominant irritable bowel syndromePatrick Cole, Xavier Rabasseda
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Drug News & Perspectives|February 16, 2010
Accelerating drug development and approvalPatrick Cole
Drug News & Perspectives|February 18, 2009
Insights into inflammatory mechanisms and new therapeutic strategiesPatrick Cole
Drugs of Today (Barcelona, Spain : 1998)|May 10, 2003
Esomeprazole: A significant advance beyond omeprazole in the treatment of acid-related diseaseXavier Rabasseda, Patrick Cole
The Journal of Craniofacial Surgery|November 13, 2007
Mental training in surgical education: a randomized, controlled trialPatrick Cole, Larry Hollier
Drug News & Perspectives|April 7, 2010
Chronicles in drug discoveryPatrick Cole, Sylvia Vasiliou
Drugs of Today (Barcelona, Spain : 1998)|February 13, 2003
Frovatriptan: a selective type 1B/1D serotonin receptor agonist for the treatment of migraine headachePatrick Cole, Xavier Rabasseda
Drugs of Today (Barcelona, Spain : 1998)|December 18, 2004
Quetiapine in bipolar disorder: Increasing evidence of efficacy and tolerabilityPatrick Cole, Xavier Rabasseda
Drugs of Today (Barcelona, Spain : 1998)|August 6, 2005
Enhanced hypercholesterolemia therapy: the ezetimibe/simvastatin tabletPatrick Cole, Xavier Rabasseda
Drug News & Perspectives|December 18, 2009
Chronicles in drug discoveryPatrick Cole, Sylvia Vasiliou
Drugs of Today (Barcelona, Spain : 1998)|January 13, 2005
Tegaserod: a serotonin 5-HT4 receptor agonist for treatment of constipation-predominant irritable bowel syndromePatrick Cole, Xavier Rabasseda
Pageof 7